For once, you'll want to install this update ASAP.

Excitement is building within the Chennai Super Kings camp as legendary former captain MS Dhoni is likely to travel with the squad to Lucknow ahead of their crucial IPL 2026 clash against Lucknow ...

A security researcher has released a proof-of-concept tool named GhostLock that demonstrates how a legitimate Windows file API can be abused in attacks to block access to files stored locally or on ...

PCWorld reports that Windows 11 still relies on code from the 1990s, particularly the Win32 API from Windows 95, for basic functions like right-clicking. Microsoft CTO Mark Russinovich acknowledges ...

After a series of regulatory and clinical setbacks for Sanofi’s tolebrutinib, the French pharma has scored a victory for the multiple sclerosis (MS) candidate. Thursday, Europe’s Committee for ...

Michael Shvo picked up a win in his legal fight with the exclusive Core Club at 711 Fifth Avenue. A judge recently found the members-only venue in contempt of an order to check IDs of visitors in the ...

Microsoft’s MSFT stock has been dragged down with other software names this year as investors question how artificial intelligence may disrupt their business models. But we don’t think AI will harm ...

Core Storage containers are one of the many different crates in Marathon. As the name suggests, these containers have cores in them, along with a few other Salvage items. The main difficulty is ...

ORLANDO, Fla. – Many probably thought the rainbow that crossed the sky late Sunday afternoon at Bay Hill was just Arnold Palmer looking down on the latest champion of his tournament. Akshay Bhatia ...

Crypto just took a big step closer to becoming integrated into the mainstream financial system. Kraken’s banking unit has won access to the Federal Reserve’s core payment systems, making it the first ...

Réparez le plantage d'Adobe Reader sur Windows 7 causé par la dépendance à api-ms-win-core-winrt-l1-1-0.dll après les mises à jour 2026. ⚠️ Windows 7 UNIQUEMENT — Windows 8, 8.1, 10 et 11 contiennent ...

A second phase 3 study of Roche’s fenebrutinib in relapsing multiple sclerosis (RMS) has hit its primary endpoint, positioning the company to submit the BTK inhibitor for approval. But the discovery ...